Genes,
Journal Year:
2024,
Volume and Issue:
15(12), P. 1653 - 1653
Published: Dec. 23, 2024
Background:
Neurodevelopmental
disorders
(NDDs)
affect
approximately
15%
of
children
and
adolescents
worldwide.
This
group
is
often
polygenic
with
varying
risk
factors,
many
associated
genes
converging
on
shared
molecular
pathways,
including
chromatin
regulation
transcriptional
control.
Understanding
how
NDD-associated
regulators
protein
complexes
orchestrate
these
regulatory
pathways
crucial
for
elucidating
NDD
pathogenesis
developing
targeted
therapeutic
strategies.
Recently,
the
TCF20/PHF14
complex
was
identified
in
mammalian
brain,
expanding
list
remodelers
implicated
NDDs.
complex—which
includes
MeCP2,
RAI1,
TCF20,
PHF14,
HMG20A—plays
a
vital
role
epigenetic
regulation.
Methods:
We
review
summarize
current
research
clinical
reports
pertaining
to
different
components
MeCP2-interacting
complex.
examine
NDDs
complex,
explore
neuronal
functions
its
components,
discuss
emerging
strategies
targeting
this
mitigate
symptoms,
broader
applicability
other
Results:
Mutations
encoding
have
been
linked
various
NDDs,
underscoring
critical
contribution
brain
development
pathogenesis.
Conclusions:
The
could
serve
as
model
system
provide
insight
into
interplay
between
Science Advances,
Journal Year:
2025,
Volume and Issue:
11(9)
Published: Feb. 26, 2025
3D
organization
of
the
genome
plays
a
critical
role
in
regulating
gene
expression.
How
3D-genome
differs
among
different
cell
types
and
relates
to
type–dependent
transcriptional
regulation
remains
unclear.
Here,
we
used
genome-scale
DNA
RNA
imaging
investigate
transcriptionally
distinct
mouse
cerebral
cortex.
We
uncovered
wide
spectrum
differences
nuclear
architecture
types,
ranging
from
size
nucleus
higher-order
chromosome
structures
radial
positioning
chromatin
loci
within
nucleus.
These
variations
exhibit
strong
correlations
with
both
total
activity
type–specific
marker
genes.
Moreover,
found
that
methylated
binding
protein
MeCP2
promotes
active-inactive
segregation
regulates
transcription
position–dependent
manner
is
highly
correlated
its
function
modulating
compartmentalization.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 22, 2024
Introduction
Alzheimer’s
disease
(AD)
is
one
of
the
most
prevalent
forms
dementia
globally
and
remains
an
incurable
condition
that
often
leads
to
death.
PANoptosis
represents
emerging
paradigm
in
programmed
cell
death,
integrating
three
critical
processes:
pyroptosis,
apoptosis,
necroptosis.
Studies
have
shown
necroptosis,
pyroptosis
play
important
roles
AD
development.
Therefore,
targeting
genes
might
lead
novel
therapeutic
targets
clinically
relevant
approaches.
This
study
aims
identify
different
molecular
subtypes
potential
drugs
for
treating
based
on
PANoptosis.
Methods
Differentially
expressed
associated
with
were
identified
via
Gene
Expression
Omnibus
(GEO)
dataset
GSE48350,
GSE5281,
GSE122063.
Least
Absolute
Shrinkage
Selection
Operator
(LASSO)
regression
was
employed
construct
a
risk
model
linked
these
genes.
Consensus
clustering
analysis
conducted
define
We
further
performed
gene
set
variation
(GSVA),
functional
enrichment
analysis,
immune
infiltration
investigate
differences
between
subtypes.
Additionally,
protein-protein
interaction
(PPI)
network
established
hub
genes,
DGIdb
database
consulted
compounds
Single-cell
RNA
sequencing
utilized
assess
expression
at
cellular
level
across
Results
A
total
24
differentially
(APANRGs)
AD,
leading
classification
two
distinct
subgroups.
The
results
indicate
subgroups
exhibit
varying
progression
states,
early
subtype
primarily
dysfunctional
synaptic
signaling.
Furthermore,
we
from
(DEGs)
clusters
predicted
38
candidate
treatment
revealed
key
are
predominantly
neuronal
cells,
while
differential
metabolic
found
endothelial
cells
astrocytes.
Conclusion
In
summary,
subtypes,
including
abnormality
as
well
immune-metabolic
subtype.
ten
SLC17A7,
SNAP25,
GAD1,
SLC17A6,
SLC32A1,
PVALB,
SYP,
GRIN2A,
SLC12A5,
SYN2,
marker
These
findings
may
provide
valuable
insights
diagnosis
contribute
development
innovative
strategies.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 13, 2024
MeCP2
is
a
DNA-binding
transcriptional
regulator
that
present
at
near-histone
levels
in
mammalian
cortical
neurons.
Originally
identified
as
DNA
methylation
reader,
has
been
proposed
to
repress
transcription
by
recruiting
corepressors
methylated
DNA.
While
some
genome-wide
occupancy
studies
support
preference
for
DNA,
others
suggest
binding
more
influenced
sequence
and
accessibility
than
status.
Moreover,
multiple
also
role
gene
activation.
To
clarify
function
we
expressed
Saccharomyces
cerevisiae
,
which
lacks
known
corepressors.
We
find
toxic
yeast
globally
inhibits
transcription,
indicating
can
have
significant
functional
impacts
without
or
A
subset
of
mutations
cause
the
neurodevelopmental
disorder
Rett
syndrome,
particularly
those
map
domain,
alleviate
toxicity
yeast.
Consistent
with
importance
yeast,
show
binds
genome,
increased
GC-rich,
nucleosome-depleted
sequences.
These
findings
useful
tool
analyzing
reveal
properties
are
not
strictly
dependent
on